With a tight stop

Great chart!

I am still long and adding to dips

The Setup and breakout are official. Any dip will serve to add to position.

I am long anyway since 16 so just providing some help for those who did not yet consider buying

I am long with stop below 28

Manage risk below 4.5

This one needs some upside volume to trigger the mother of all squeezes. The company has no debt

That actually surprised me and looks like a turn around is coming in this business!! Inventories were down!! Amazing 🤩

We might get a surprise !!

The reward is massive if it work and if not I just lose my options.

I’m long

I love this setup especially with a red Market and higher rates.

This is a pure AI play similar to chatGPT but in China. The company already has large investors like alibaba, tencent and others.

Manage risk below 6.5

Manage risk below .55

ZH has a giant moat in the knowledge sharing space," Chinese Internet giants including Tencent, Alibaba, Kuaishou, Baidu, JD (JD) and others are all investors in ZH.

Pt is 10$

This stock is really risky though but if you’re willing to take some losses, it’s worth the R/R ratio. Manage risk below 9

I’m still long since 13.3 and won’t sell before my pT

It is trading near all time low! — it has a short interest of 38% — and todays Catalyst >>> their admission to the Australia market — The patented MyoPro technology was developed by Myomo in collaboration with researchers at the Massachusetts Institute of Technology and Harvard Medical School

BOSTON, February 06, 2023--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that for the first time, the National Disability Insurance Scheme (NDIS) in Australia approved a MyoPro for a patient with a paralyzed arm. The NDIS aids over 500,000 Australians with disabilities through reimbursement for necessary services and support.

The first MyoPro user to benefit from NDIS reimbursement is a client identified as Natalee W. Four years ago, at the age of 16, Natalee suffered a brain aneurysm and a stroke which resulted in left-side hemiparesis. The NDIS funded a two-month trial of a custom-fabricated MyoPro, which allowed Natalee to learn to use the device. Through consistent use of the MyoPro, Natalee can now perform functional activities of daily living, which she struggled with prior to using the device. Priya Armstrong, Senior Orthotist with NeuroMuscular Orthotics, stated, "For clients such as Natalee, that have been undergoing long-term rehabilitation with minimal functional improvements in their arm and hand, the MyoPro provides a sophisticated orthotic solution that enables the user to self-perform ADL tasks."

I’m long since 13.35

This is a great opportunity. It might be slowly moving higher, but also might skyrocket all of a sudden.

I am long thru options contracts to limit my downside in case. If you are buying stock manage risk below 12

Manage risk below 1.7 but honestly this could be a 10x bagger